Axon Enterprise, Inc (NASDAQ:AXON) Stake Lifted by Flagship Harbor Advisors LLC

Flagship Harbor Advisors LLC increased its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 2.0% in the 1st quarter, HoldingsChannel reports. The fund owned 1,863 shares of the biotechnology company’s stock after acquiring an additional 37 shares during the period. Flagship Harbor Advisors LLC’s holdings in Axon Enterprise were worth $980,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Pinion Investment Advisors LLC boosted its holdings in shares of Axon Enterprise by 3.0% in the first quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company’s stock valued at $341,000 after acquiring an additional 19 shares in the last quarter. Kentucky Retirement Systems boosted its holdings in Axon Enterprise by 0.4% during the first quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company’s stock worth $2,605,000 after buying an additional 19 shares in the last quarter. Beacon Pointe Advisors LLC boosted its holdings in Axon Enterprise by 2.6% during the fourth quarter. Beacon Pointe Advisors LLC now owns 864 shares of the biotechnology company’s stock worth $513,000 after buying an additional 22 shares in the last quarter. Fielder Capital Group LLC boosted its holdings in Axon Enterprise by 2.2% during the fourth quarter. Fielder Capital Group LLC now owns 1,176 shares of the biotechnology company’s stock worth $699,000 after buying an additional 25 shares in the last quarter. Finally, Interchange Capital Partners LLC boosted its holdings in Axon Enterprise by 1.9% during the fourth quarter. Interchange Capital Partners LLC now owns 1,310 shares of the biotechnology company’s stock worth $779,000 after buying an additional 25 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Up 1.4%

AXON stock opened at $794.25 on Wednesday. Axon Enterprise, Inc has a 12-month low of $279.02 and a 12-month high of $806.64. The company has a quick ratio of 2.62, a current ratio of 2.83 and a debt-to-equity ratio of 0.68. The company has a market cap of $61.83 billion, a price-to-earnings ratio of 191.85, a PEG ratio of 90.16 and a beta of 1.29. The company has a 50 day moving average of $700.64 and a two-hundred day moving average of $627.10.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The company had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same quarter in the prior year, the firm earned $1.15 EPS. The company’s revenue was up 31.3% compared to the same quarter last year. On average, equities analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CAO Jennifer H. Mak sold 75 shares of Axon Enterprise stock in a transaction on Friday, June 13th. The shares were sold at an average price of $771.81, for a total value of $57,885.75. Following the completion of the sale, the chief accounting officer now owns 15,240 shares of the company’s stock, valued at approximately $11,762,384.40. The trade was a 0.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, President Joshua Isner sold 905 shares of Axon Enterprise stock in a transaction on Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total transaction of $702,632.95. Following the completion of the sale, the president now directly owns 268,735 shares of the company’s stock, valued at approximately $208,643,166.65. The trade was a 0.34% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 44,642 shares of company stock worth $30,500,428 in the last quarter. 5.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on AXON shares. Bank of America raised their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a “buy” rating in a report on Wednesday, June 4th. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. Barclays raised their target price on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an “overweight” rating in a report on Friday, May 9th. The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a research note on Wednesday, May 14th. Finally, Needham & Company LLC raised their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a research note on Thursday, May 8th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the stock. According to MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus price target of $699.55.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.